All Biotechnology articles – Page 3
-
Article
Cabaletta Bio appoints chief compliance officer
Clinical-stage biotechnology company Cabaletta Bio promoted Heather Harte-Hall to the role of chief compliance officer.
-
Article
Twist Bioscience appoints chief ethics and compliance officer
Synthetic biology and genomics company Twist Bioscience Corporation has appointed Dennis Cho as senior vice president, general counsel, and chief ethics and compliance officer.
-
ArticleCherry Bekaert audit partner facing SEC scrutiny over MiMedx fraud case
The Securities and Exchange Commission is considering whether to pursue enforcement against a certified public accountant for his alleged role in an accounting fraud case the agency brought against biotech company MiMedx Group.
-
Article
Axogen names new chief compliance officer
Axogen, a developer of surgical solutions, announced the appointment of Brad Ottinger as general counsel and chief compliance officer to replace the retiring Greg Freitag.
-
ArticleMiMedx names new accounting chief post fraud settlement
Biotech company MiMedx Group, which last November settled an alleged case of accounting fraud with the SEC, announced the appointment of William Phelan as senior vice president and chief accounting officer.
-
Article
Imara appoints general counsel
Biopharmaceutical firm Imara announced the appointment of Stephen Migausky as senior vice president, legal and general counsel.
-
ArticleFTC, FDA to enhance antitrust oversight in biologics market
The Federal Trade Commission and Food and Drug Administration have signaled they will be increasing their oversight of any potential antitrust behavior in the biologics market.
-
Article
SEC charges MiMedx Group with accounting fraud
Biotech company MiMedx Group and three of its former top executives have been charged with defrauding investors. In response, MiMedx reshuffled its management team, including the appointment of a new general counsel and secretary.
- Previous Page
- Page1
- Page2
- Page3
- Next Page